Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) An author's correction has been published Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by DelVecchio, A. Articles by Sriprakash, K. S. Search for Related Content PubMed PubMed Citation Articles by DelVecchio, A. Articles by Sriprakash, K. S.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, July 2002, p. 2642-2644, Vol. 40, No. 7
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.7.2642-2644.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

NAD-Glycohydrolase Production and speA and speC Distribution in Group A Streptococcus (GAS) Isolates Do Not Correlate with Severe GAS Diseases in the Australian Population

Armando DelVecchio,¹ Michael Maley,² Bart J. Currie,^1,3 and K. S. Sriprakash^1,3,4*

Menzies School of Health Research,¹ Co-operative Research Centre for Aboriginal and Tropical Health, Darwin,³ Queensland Institute of Medical Research, Brisbane,⁴ South Western Area Pathology Services, Liverpool, Sydney, Australia²

Received 14 January 2002/ Returned for modification 7 April 2002/ Accepted 21 April 2002

Top Abstract Text References

 
Streptococcus pyogenes isolates from a tropical region and a subtropical region of Australia with high and low incidences of severe streptococcal diseases, respectively, were analyzed for speA, speB, and speC gene distributions and NAD-glycohydrolase expression. No direct correlation of these characteristics with a propensity to cause invasive diseases was observed.

Top Abstract Text References

 
Group A streptococcus (GAS; Streptococcus pyogenes) is generally considered a mucosal or skin pathogen responsible for pharyngitis and impetigo. However, the organism can also cause severe invasive diseases such as necrotizing fasciitis, toxic shock syndrome, and cellulitis; and the incidences of these diseases have increased in developed nations (3, 14). Although the clonal spread of some strains has been noted during some invasive disease outbreaks (8), this is not always observed (5). S. pyogenes expresses several excretory proteins which may have a role in virulence and pathogenesis. Whereas genes for many of these virulence factors are present in all GAS strains, other virulence genes have restricted distributions (2, 18, 21). The correlation between the distribution of speA (the gene for erythrogenic toxin A) or its expression and the course of streptococcal disease has been investigated and has yielded conflicting results (7, 9, 13, 17, 18, 21). The level of expression of extracellular cysteine protease (SpeB) was reported to be low in GAS isolates from patients with severe disease in Canada (15); however, no such correlation was found in a study performed elsewhere (17).

All GAS strains carry the gene encoding NAD-glycohydrolase (NADase). However, only some strains express this enzyme (1, 20). Ninety-two percent of GAS strains isolated from patients involved in an outbreak of GAS infection in Texas which caused invasive diseases and death produced NADase (1). In addition, serotype M1 isolates obtained prior to 1988, i.e., prior to the resurgence of invasive GAS diseases, are generally negative for NADase production; but M1 isolates obtained after 1988 are generally positive for this phenotype (20). These observations suggest a role for NADase in the pathogenesis of invasive GAS infections.

The Northern Territory (NT) of Australia has the greatest diversity of GAS strains per capita reported in the world (11, 12). In this region the epidemiology of GAS does not appear to follow the epidemiological patterns found elsewhere (4, 5). The rate of streptococcal invasive diseases among the indigenous population is five times that among the general population, and no single S. pyogenes clone has been shown to be dominant (5). We now report on the distribution of the genes for three erythrogenic toxins (speA, speB, and speC) and NADase activity in GAS strains from the NT and from southwestern Sydney (SWS), a subtropical region. For this study we selected distinct molecular types of GAS from the two regions to avoid potential representation of multiple clonal isolates in the analysis. The isolates were genotyped (vir typed) as described by Gardiner et al. (10). Thirty-seven vir types were detected among GAS strains isolated from cultures of blood from patients admitted to Royal Darwin Hospital, a major hospital in the tropical top end of the NT, from 1990 to 1997 for bacteremia (n = 35) and necrotizing fasciitis (n = 2). Seventy-three percent of the patients with invasive disease were of Aboriginal descent. Thirty-eight vir types were detected among GAS strains isolated from patients with uncomplicated infections in the same geographic area during the same period. Thirty-nine vir types were found among isolates causing invasive and uncomplicated infections in SWS between 1996 and 1999, with six vir types being commonly detected in patients with both types of infections. These six vir types were proportionately distributed between patients with the two types of infections. Thus, for this study, 26 distinct vir types were obtained from patients with invasive cases of disease and 13 distinct vir types were obtained from patients with noninvasive cases of disease. Thus, the 114 genotypes analyzed in this study comprised 63 vir types from patients with invasive cases of disease (necrotizing fasciitis, toxic shock syndrome, cellulitis, bacteremia) and 51 vir types from patients with uncomplicated infections from the NT and SWS. No dominant GAS clone was identified among patients with invasive cases of disease in either region (5; M. Maley et al., unpublished data). Every isolate within each region had a distinct genotype, as determined by vir typing. The genotypes of the isolates recovered from patients in the NT represented nearly three-quarters of the circulating vir types identified in the NT, and the genotypes of the isolates recovered from patients in SWS represented 100% of the vir types identified in that region from 1996 to 1999. Apart from selecting for a unique genotype as determined by vir typing, no other means of selection was applied to either of the sets of isolates.

The GAS isolates were grown in Todd-Hewitt broth supplemented with 0.02% yeast extract and 20 mM glycine at 37°C, and DNA was extracted as described previously (6, 12). Screening for speA, speB, and speC was carried out by PCR as described previously (7, 19). The isolates of all vir types possessed the speB gene, confirming the results of studies with strains from other geographic areas (22). The distributions of speA or speC among the isolates from patients with invasive and noninvasive cases of disease in the NT and in the SWS region were not significantly different (Table 1). Thus, it appears that the presence of speA or speC does not correlate with severe invasive diseases in the two areas of Australia where isolates for the present study were recovered, one with tropical climatic conditions and the other with subtropical climatic conditions. Large numbers of distinct GAS strains are circulating in both regions, and the populations of these two areas have disparately different life-styles and socioeconomic conditions.

View this table: [in this window] [in a new window]

TABLE 1. Relative distributions of the genes for streptococcal pyrogenic exotoxins A and C and ability to express NADase among strains isolated from patients with invasive and non invasive disease from the NT and SWS regions of Australia

To measure NADase activity in culture supernatants, overnight cultures of GAS were clarified by centrifugation at 2,000 x g for 10 min. The assay mixture contained 25 µl each of 100 mM potassium phosphate buffer (pH 7.3) with 0.1% bovine serum albumin (Sigma), GAS culture supernatant, and NAD (1.8 mg/ml; Sigma). The mixture was poured into the wells of 96-well plates. After incubation at 37°C in 5% CO₂ for 20 min, 50 µl of 5 M NaOH was added to each well and the plates were incubated in the dark for 1 h at room temperature. Fluorescence was measured (excitation, 360 nm; emission, 508 nm) in a microplate fluorescence reader (FL600; BioTek). The negative control contained 25 µl of growth medium in place of culture supernatant in the assay mixture. All samples were assayed in duplicate. A standard curve for the NADase assay was established with commercial NADase (Sigma). NADase-positive strains decreased the amount of NAD in the assay mixture by greater than 30% and were easily distinguished from the negative strains by this assay. Our results, which demonstrated a lack of association between NADase activity and a propensity to cause invasive diseases (Table 1), are in contrast to the results of an earlier study (1). It is possible that host factors and clonal spread (or the lack of it) could explain the contrasting results, but a lack of typing information in the earlier study (1) prevents an appraisal.

Interestingly, overall a significantly greater proportion of the SWS strains than the NT strains were found to harbor the speC gene (51 versus 24%, respectively; P = 0.0034) or express NADase (77 versus 45%, respectively; P = 0.0013), and the results appear to show an inverse correlation between these characteristics and the incidence of severe diseases, as the overall crude incidence of severe GAS-associated diseases in the NT (9.3 per 100,000 population per year [5]) is higher than that in SWS (1.45 per 100,000 population per year [Maley et al., unpublished]). Cytolysin-mediated delivery of NADase into host cells (16), the ability of NADase to induce cellular changes through cyclic ADP-ribose synthesis, and other recent studies (1, 20) implicitly attribute a role for this enzyme in the pathogenesis of invasive diseases. However, the work described here does not lend support to such a simple interpretation. Contributions of host and other bacterial factors may be important in influencing the disease outcomes.

In summary, while we have not observed a correlation between the distribution of speA or speC or NADase expression and GAS-associated invasive diseases in two locations in Australia, the significantly higher proportions of speC- and NADase-positive strains from SWS (where there is a relatively low incidence of GAS-associated invasive diseases) than among strains from the NT (where there is a relatively high incidence of GAS-associated invasive diseases) remain unexplained.

 
The National Health and Medical Research Council of Australia supported the work.

We thank David McMillan for critical reading of the manuscript.

 
* Corresponding author. Mailing address: 300, Herston Rd., Herston, Qld 4006, Australia. Phone: 61-7-33620407. Fax: 61-7-33620104. E-mail: sriS{at}qimr.edu.au.

Top Abstract Text References

 

1
1. Ajdic, D., W. M. McShan, D. J. Savic, D. Gerlach, and J. J. Ferretti. 2000. The NAD-glycohydrolase (nga) gene of Streptococcus pyogenes. FEMS Microbiol. Lett. 191:235-241.[CrossRef][Medline]
2
2. Akesson, P., A. G. Sjoholm, and L. Bjorck. 1996. Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function. J. Biol. Chem. 271:1081-1088.[Abstract/Free Full Text]
3
3. Carapetis, J., R. Robins-Browne, D. Martin, T. Shelby-James, and G. Hogg. 1995. Increasing severity of invasive group A streptococcal disease in Australia: clinical and molecular epidemiological features and identification of a new virulent M-nontypeable clone. Clin. Infect. Dis. 21:1220-1227.[Medline]
4
4. Carapetis, J. R., and B. J. Currie. 1996. Group A streptococcus, pyoderma, and rheumatic fever. Lancet 347:1271-1272.[Medline]
5
5. Carapetis, J. R., A. M. Walker, M. Hibble, K. S. Sriprakash, and B. J. Currie. 1999. Clinical and epidemiological features of group A streptococcal bacteraemia in a region with hyperendemic superficial streptococcal infection. Epidemiol. Infect. 122:59-65.[CrossRef][Medline]
6
6. Chassy, B. M., E. Gibson, and A. Giuffrida. 1976. Evidence for extrachromosomal elements in Lactobacillus. J. Bacteriol. 127:1576-1578.[Abstract/Free Full Text]
7
7. Chatellier, S., N. Ihendyane, R. G. Kansal, F. Khambaty, H. Basma, A. Norrby-Teglund, D. E. Low, A. McGeer, and M. Kotb. 2000. Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect. Immun. 68:3523-3534.[Abstract/Free Full Text]
8
8. Cleary, P. P., E. L. Kaplan, J. P. Handley, A. Wlazlo, M. H. Kim, A. R. Hauser, and P. M. Schlievert. 1992. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet 339:518-521.[CrossRef][Medline]
9
9. Descheemaeker, P., F. Van Loock, M. Hauchecorne, P. Vandamme, and H. Goossens. 2000. Molecular characterisation of group A streptococci from invasive and non-invasive disease episodes in Belgium during 1993-1994. J. Med. Microbiol. 49:467-471.[Abstract/Free Full Text]
10
10. Gardiner, D., J. Hartas, B. Currie, J. D. Mathews, D. J. Kemp, and K. S. Sriprakash. 1995. Vir typing: a long-PCR typing method for group A streptococci. PCR Methods Appl. 4:288-293.[Medline]
11
11. Gardiner, D., J. Hartas, M. Hibble, A. Goodfellow, B. Currie, and K. S. Sriprakash. 1997. Molecular epidemiology of group A streptococcal infection in the Northern Territory of Australia. Adv. Exp. Med. Biol. 418:317-321.[Medline]
12
12. Gardiner, D. L., and K. S. Sriprakash. 1996. Molecular epidemiology of impetiginous group A streptococcal infections in aboriginal communities of northern Australia. J. Clin. Microbiol. 34:1448-1452.[Abstract]
13
13. Hauser, A. R., D. L. Stevens, E. L. Kaplan, and P. M. Schlievert. 1991. Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. J. Clin. Microbiol. 29:1562-1567.[Abstract/Free Full Text]
14
14. Hoge, C. W., B. Schwartz, D. F. Talkington, R. F. Breiman, E. M. MacNeill, and S. J. Englender. 1993. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA 269:384-389.[Abstract/Free Full Text]
15
15. Kansal, R. G., A. McGeer, D. E. Low, A. Norrby-Teglund, and M. Kotb. 2000. Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect. Immun. 68:6362-6369.[Abstract/Free Full Text]
16
16. Madden, J. C., N. Ruiz, and M. Caparon. 2001. Cytolysin-mediated translocation (CMT): a functional equivalent of type III secretion in gram-positive bacteria. Cell 104:143-152.[CrossRef][Medline]
17
17. Mascini, E. M., M. Jansze, L. M. Schouls, A. C. Fluit, J. Verhoef, and H. van Dijk. 1999. Invasive and noninvasive group A streptococcal isolates with different speA alleles in The Netherlands: genetic relatedness and production of pyrogenic exotoxins A and B. J. Clin. Microbiol. 37:3469-3474.[Abstract/Free Full Text]
18
18. Musser, J. M., A. R. Hauser, M. H. Kim, P. M. Schlievert, K. Nelson, and R. K. Selander. 1991. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc. Natl. Acad. Sci. USA 88:2668-2672.[Abstract/Free Full Text]
19
19. Norgren, M., A. Norrby, and S. E. Holm. 1992. Genetic diversity in T1M1 group A streptococci in relation to clinical outcome of infection. J. Infect. Dis. 166:1014-1020.[Medline]
20
20. Stevens, D. L., D. B. Salmi, E. R. McIndoo, and A. E. Bryant. 2000. Molecular epidemiology of nga and NAD glycohydrolase/ADP-ribosyltransferase activity among Streptococcus pyogenes causing streptococcal toxic shock syndrome. J. Infect. Dis. 182:1117-1128.[CrossRef][Medline]
21
21. Talkington, D. F., B. Schwartz, C. M. Black, J. K. Todd, J. Elliott, R. F. Breiman, and R. R. Facklam. 1993. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect. Immun. 61:3369-3374.[Abstract/Free Full Text]
22
22. Tyler, S. D., W. M. Johnson, J. C. Huang, F. E. Ashton, G. Wang, D. E. Low, and K. R. Rozee. 1992. Streptococcal erythrogenic toxin genes: detection by polymerase chain reaction and association with disease in strains isolated in Canada from 1940 to 1991. J. Clin. Microbiol. 30:3127-3131.[Abstract/Free Full Text]

---

Journal of Clinical Microbiology, July 2002, p. 2642-2644, Vol. 40, No. 7
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.7.2642-2644.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Commons, R., Rogers, S., Gooding, T., Danchin, M., Carapetis, J., Robins-Browne, R., Curtis, N. (2008). Superantigen genes in group A streptococcal isolates and their relationship with emm types. J Med Microbiol 57: 1238-1246 [Abstract] [Full Text]  
• Bricker, A. L., Carey, V. J., Wessels, M. R. (2005). Role of NADase in Virulence in Experimental Invasive Group A Streptococcal Infection. Infect. Immun. 73: 6562-6566 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF) An author's correction has been published Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by DelVecchio, A. Articles by Sriprakash, K. S. Search for Related Content PubMed PubMed Citation Articles by DelVecchio, A. Articles by Sriprakash, K. S.